JenXplor. Abgeschlossene Ausbildung als BTA, MTA, Biologielaborant*in (m/w/div), Bachelor- oder Master-Abschluss in einer Lebenswissenschaft (z. B. Biologie, Mikrobiologie, Biochemie, Biotechnologie) oder vergleichbare

JenXplor. Abgeschlossene Ausbildung als BTA, MTA, Biologielaborant*in (m/w/div), Bachelor- oder Master-Abschluss in einer Lebenswissenschaft (z. B. Biologie, Mikrobiologie, Biochemie, Biotechnologie) oder vergleichbare

JenXplor. Abgeschlossene Ausbildung als BTA, MTA, Biologielaborant*in (m/w/div), Bachelor- oder Master-Abschluss in einer Lebenswissenschaft (z. B. Biologie, Mikrobiologie, Biochemie, Biotechnologie) oder vergleichbare

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of

At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), we investigate the pathobiology of microorganisms and develop new natural product-based active compounds for the treatment of